Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on October 31,...

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 7:30am EDT 

Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on
October 31, 2008
Conference Call Scheduled for October 31, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, Oct. 23 /PRNewswire-FirstCall/ -- Trinity Biotech plc
(Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products
for the point-of-care and clinical laboratory markets, will report financial
results for the third quarter of fiscal year 2008 on Friday, October 31, 2008.
The Company has scheduled a conference call for that same day, Friday, October
31, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.
    Interested parties can access the call by dialing:

        USA:            1-877-356-5706
        International:  1-706-679-3820

    A simultaneous webcast of the call can be accessed at:
    http://www.videonewswire.com/event.asp?id=52570

    A replay of the call can be accessed until November 3, 2008 by dialing:

        USA:                 1-800-642-1687
        International:       1-706-645-9291
        Conference ID #:     69804141

    The webcast of the call will be available for 30 days at:
    http://www.videonewswire.com/event.asp?id=52570

    About Trinity Biotech plc
    Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires
manufactures and markets over 500 diagnostic products for the point-of-care
and clinical laboratory segments of the diagnostic market. The broad line of
test kits are used to detect infectious diseases, sexually transmitted
diseases, blood coagulation disorders, and autoimmune diseases. Trinity
Biotech sells worldwide in over 80 countries through its own sales force and a
network of international distributors and strategic partners.
    For further information please see the company's website:
    http://www.trinitybiotech.com.

     Contact:
     Ms. Niamh Long                 Joe Diaz, Joe Dorame and Robert Blum
     Trinity Biotech plc            Lytham Partners, LLC
     Investor Relations Officer     602-889-7900
     (800) 603-8076

SOURCE  Trinity Biotech plc

Ms. Niamh Long, Trinity Biotech plc Investor Relations Officer,
1-800-603-8076; or Joe Diaz, Joe Dorame or Robert Blum, all of Lytham
Partners, LLC, +1-602-889-7900, for Trinity Biotech plc
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.